Marché mondial des nano-bioréacteurs – Tendances et prévisions de l’industrie jusqu’en 2030

Analyse du marché et de la taille des nano-bioréacteurs

La demande croissante de médicaments personnalisés aura un impact majeur sur la dynamique de l'industrie des bioréacteurs. L'incidence croissante des maladies chroniques a conduit à une augmentation des initiatives de sensibilisation associées aux développements récents des médicaments personnalisés. La croissance des bioréacteurs dans les produits pharmaceutiques, les avancées technologiques dans les bioréacteurs et l'adoption croissante des bioréacteurs à usage unique (SUB) et des bioréacteurs hybrides sont les principaux facteurs responsables de la croissance actuelle du marché des bioréacteurs.  

Data Bridge Market Research analyse le taux de croissance du marché des nano-bioréacteurs au cours de la période de prévision 2023-2030. Le TCAC attendu du marché des nano-bioréacteurs a tendance à être d'environ 8,50 % au cours de la période de prévision mentionnée. Le marché était évalué à 3,28 milliards USD en 2022 et devrait atteindre 6,3 milliards USD d'ici 2030. En plus des informations sur le marché telles que la valeur marchande, le taux de croissance, les segments de marché, la couverture géographique, les acteurs du marché et le scénario du marché, le rapport de marché organisé par l'équipe de recherche sur le marché de Data Bridge comprend également une analyse approfondie des experts, une épidémiologie des patients, une analyse du pipeline, une analyse des prix et un cadre réglementaire.

Portée et segmentation du marché des nano-bioréacteurs

Market Definition

Nano bioreactors are designed to make process development and small scale production of virus for vaccines or gene therapy easy and straightforward. These are vessels that have been designed and produced to offer an effective environment for enzymes or whole cells to transform biochemicals into products. In many of the cases, the inactivation of cells or sterilization is carried out in the bioreactor such as in water treatment.

Global Nano Bioreactor Market Dynamics

Drivers

• Increasing Use of Recombinant Proteins

Recombinant proteins molecule is estimated to increase the growth of the market. Recombinant proteins have evolved as a prominent tool in medical research combined with promising effects against pathogen antigens. They are widely used as therapeutic proteins and replacement therapies, particularly in cases of hormonally active substances such as insulin and growth factor.  Thus, this factor increase the market growth.

• Increasing Funding by Government Organizations

Growing investments in R&D activities leading to developing novel treatments for chronic ailments will boost the need for bioreactors at research firms. These initiatives are implemented globally to address the rising cases of diabetes, cancer, respiratory diseases, and cardiovascular disorders. Growing focus on drug development is anticipated to boost the demand for bioreactors at R&D organizations.

Opportunities

• Rising Adoption Of Single-Use Bioreactors Due To Growing Infections

Single-use bioreactors are widely used in R&D and the production of novel vaccines. With the development of new infectious diseases such as COVID-19, numerous pharma companies have increased the adoption of these technologies. Numerous end-users are converting to single-use products because of advantages such as flexible process flow, cost-effectiveness, and lower cost of the material. Numerous advancements in miniaturized single-use bioreactors are further allowing R&D organizations to assuring cost efficiency. Thus, this factor significantly increases the market growth.

• Growing Use of Hybrid Bioreactor Technology

The wide use of hybrid bioreactor technology in effective waste management has increased the expansion of the market. Several initiatives by major market players are also boosting the market growth. For instance, Beckman Coulter Life Sciences launched its next-generation Biolector XT Microbioreactor in Germany in May 2021. The BioLector XT Microbioreactor enables high-throughput strain screenings, cultivation parameter monitoring, and feeding strategy optimization.​ Thus, this increasing expenditure will increase the growth rate.

 Restraints/Challenges

• Limited Space of Bioreactors  

The biggest disadvantage of nanobioreactors lies in its scaling. Large, flat rocker bioreactors do not scale well. They usually vary from only 5 to 100 L, with their size restricted by the rate of oxygen transfer through the headspace. Thus, this restraint hinders the usage of nanobioreactors by market players and organizations.

This nano bioreactor market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the nano bioreactor market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

Recent Developments

• In 2022, Getinge AB announced that their bioreactors will support the Dutch government's initiative to manufacture animal products such as meat and milk proteins directly from animal and microbial cells.

Global Nano Bioreactor Market Scope

The nano bioreactor market is segmented on the basis of material, cell, usage, molecule, control type, technology and end-user. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.

Material

• Glass
• Stainless Steel
• Single-Use

Cell

• Mammalian Cells
• Bacterial Cells
• Yeast Cells

Usage

• Lab-Scale Production
• Pilot-Scale Production
• Full-Scale Production

Molecule

• Monoclonal Antibodies
• Vaccines
• Recombinant Proteins
• Stem Cells
• Gene Therapy

Control Type

• Manual
• Automated (MFCs)

Technology

• Wave-Induced Motion SUB
• Stirred SUB
• Single-Use Bubble Column

End User

• Hospitals
• Homecare
• Specialty Clinics
• Others

Distribution Channel

• Hospital Pharmacy
• Online Pharmacy
• Retail Pharmacy

Nano Bioreactor Market Regional Analysis/Insights

The nano bioreactor market is analyzed and market size insights and trends are provided by material, cell, usage, molecule, control type, technology and end-user as referenced above.

The major countries covered in the nano bioreactor market report are the U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.

Asia-Pacific has been witnessing a positive growth for nano bioreactor market throughout the forecast period because of the numerous strategies, such as mergers and acquisitions research and development and product launches. Furthermore, the increasing demand for biopharmaceutical products in the region and the focus on increasing localized production are anticipated to have a major impact on the market during the forecast period.

North America dominates the market due to the increase in collaboration among the industry and academic institutions. The U.S. holds the majority of the market in the North American region as pharmaceuticals and other hi-tech product makers have announced multimillion-dollar investments to expand manufacturing capabilities.  

The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.   

Competitive Landscape and Global Nano Bioreactor Market Share Analysis

Le paysage concurrentiel du marché des nano-bioréacteurs fournit des détails par concurrent. Les détails inclus sont la présentation de l'entreprise, les finances de l'entreprise, les revenus générés, le potentiel du marché, les investissements dans la recherche et le développement, les nouvelles initiatives du marché, la présence mondiale, les sites et installations de production, les capacités de production, les forces et les faiblesses de l'entreprise, le lancement du produit, la largeur et l'étendue du produit, la domination des applications. Les points de données ci-dessus fournis ne concernent que le marché des nano-bioréacteurs axé sur les entreprises.

Les principaux acteurs opérant sur le marché des nano-bioréacteurs comprennent :

• Sartorius AG (Allemagne)
• Thermo Fisher Scientific (États-Unis)
• General Electric (États-Unis)
• Eppendorf AG (Allemagne)
• Merck KGaA (Allemagne)
• Pall Corporation (États-Unis)
• ZETA (Inde)
• PIERRE GUÉRIN (France)
• PRaj Hipurity Systems Limited (Inde)
• Bioengineering AG (Suisse)
• Infors AG (Suisse)
• Solaris Biotechnology Srl. (Italie)
• Bbi Biotech (Allemagne)
• Bailun Biotechnology Co., Ltd. (Chine)
• PBS Biotech Inc. (États-Unis)
• CerCell A/S (Danemark)
• Groupe GEA Aktiengesellschaft (Allemagne)

SKU-55120